CSIMarket Company Name, Ticker, Industry, else..
 
Cellectar Biosciences Inc   (NASDAQ: CLRB)
 

Cellectar Biosciences Inc's Suppliers Performance

CLRB's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CLRB Costs vs Sales of Suppliers Growth

• More on CLRB Suppliers






Cellectar Biosciences Inc's Comment on Supply Chain


The company sources actinium from Northstar Medical Radioisotopes. In December 2025, it entered a multi-year supply agreement with Ionetix Corporation for Actinium-225 and Astatine-211. Finished pharmaceutical radiochemical compounds (PRCs) are supplied by AtomVie and SpectronRx, both specializing in radiopharmaceutical production. The iopofosine drug product is produced through a five-step synthetic process, with AtomVie serving as the primary supplier. Large-scale production of the iopofosine drug substance has been conducted via a contract manufacturing organization approved by the FDA and EMA. The stability of the iopofosine drug substance has been demonstrated for 60 months in desiccated and refrigerated conditions.

Cellectar Biosciences Inc's Comment on Supply Chain


The company sources actinium from Northstar Medical Radioisotopes. In December 2025, it entered a multi-year supply agreement with Ionetix Corporation for Actinium-225 and Astatine-211. Finished pharmaceutical radiochemical compounds (PRCs) are supplied by AtomVie and SpectronRx, both specializing in radiopharmaceutical production. The iopofosine drug product is produced through a five-step synthetic process, with AtomVie serving as the primary supplier. Large-scale production of the iopofosine drug substance has been conducted via a contract manufacturing organization approved by the FDA and EMA. The stability of the iopofosine drug substance has been demonstrated for 60 months in desiccated and refrigerated conditions.







CLRB's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cellectar Biosciences Inc 10.09 0.00 -20.84 11
SUBTOTAL 0.00 0.00 0.00 -


Sources: Cellectar Biosciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cellectar Biosciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.